(Mary Ann Liebert, Inc./Genetic Engineering News) Chronic neuropathic pain following a spinal cord injury is common and very difficult to treat, but a new therapeutic strategy requiring a one-time injection into the spinal column has potential to improve patient outcomes. This cutting-edge pain management strategy is described in an article published in Journal of Neurotrauma, a peer-reviewed journal from Mary Ann Liebert Inc.
Read »Navigation
User login
Visit the BiotechMashup Blog
Best upcoming scoops - Biology
- Neuropeptide Y2 Receptor (NPY2R) Expression in Saliva Predicts Feeding Immaturity in the Premature Neonate
- Immunogenicity and Tolerability after Two Doses of Non-Adjuvanted, Whole-Virion Pandemic Influenza A (H1N1) Vaccine in HIV-Infec
- Saks Fifth Avenue raises $17,000 for TGen biomedical research
- Optimizing a qPCR Gene Expression Quantification Assay for S. epidermidis Biofilms: A Comparison between Commercial Kits and a C
- A Replication Study of GWAS-Derived Lipid Genes in Asian Indians: The Chromosomal Region 11q23.3 Harbors Loci Contributing to Tr